Charting and Controlled Substances—A Primer

Join the discussion

Add your clinical experience or ask the author a question. Keep patient details out of your comments and follow our community guidelines.

Loading the discussion…

The discussion couldn’t load. A content blocker may be stopping Disqus; allow it on this site to read and post comments.


Share

Author

Lawrence F. Kobak, DPM, JD

Lawrence F. Kobak, DPM, JD

Lawrence F. Kobak, DPM, JD is senior counsel in Frier Levitt’s Healthcare Department in New York. Larry has extensive experience representing physicians in connection with licensure issues, as well as successfully defending physicians before medical boards, OPMC, OPD investigations, as well as Medicare fraud, fraud & abuse, hospital actions, RAC audits, Medicare audits, OIG fraud, healthcare fraud, medical audits, and health plan billing audits. As a licensed podiatrist prior to becoming an attorney, he served as the international president of the Academy of Ambulatory Foot and Ankle Surgery.

More articles
Cover of the November/December 2026 issue of Podiatry Management The Magazine November/December 2026 issue
Podiatry Management’s Official Newsletter

Free clinical, practice management, and industry updates in your inbox — separate from the print magazine.

See what you’ll get — read past issues →